Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
How Will PSMAddition Impact the Management of Prostate Cancer?
Journal: European urology focus
Published: May 04, 2026
PD-1/PD-L1 for prostate cancer: from clinical trials to practice.
Journal: Expert review of clinical pharmacology
Published: March 31, 2026
A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy.
Journal: Expert opinion on investigational drugs
Published: October 09, 2025
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Journal: Blood
Published: September 05, 2025
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Journal: Blood
Published: September 05, 2025
Showing 1-7 of 7
Last Updated: 09/26/2026